Effect of Xiyanping injection adjuvant therapy in children with mycoplasma pneumonia
10.3969/j.issn.1005-1678.2016.12.040
- VernacularTitle:喜炎平注射液辅助治疗对支原体肺炎患儿的临床效果观察
- Author:
Minzi LIN
;
Ying ZHENG
;
Xiaozhou ZHU
- Keywords:
Xiyanping injection;
adjuvant therapy;
children with mycoplasma pneumonia;
clara cells secrete proteins;
c-reactive protein;
procalcitonin;
interleukin-6
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(12):140-143
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of the serum Clara cell secretory protein and IL-6 levels by Xiyanping injection adjuvant therapy in children with mycoplasma pneumonia .Methods 72 cases of children with mycoplasma pneumonia from October 2014 to August 2015 in our hospital department of pediatrics were selected and randomly divided into the control group and the experiment group ,36 cases in each group.The control group were treated by erythromycin erythromycin, and azithromycin, the experiment group were treated on the base of the control group with Xiyanping injection.two groups of patients were treated for two cycles.The CRP, PCT, CCSP, IL-6 and adverse reactions were compared after treatment. Results After treatment,the clinical total effective rate in experimental group was higher than in control group (P<0.05),the CRP,PCT,CCSP and IL-6 levels were lower(P<0.05).The incidence of adverse reactions in the experimental group 8.33%was obviously lower than that of the control group 19.44% (P<0.05).Conclusion Xianyanping injection adjuvant treatment of mycoplasma pneumonia in children with significant clinical efficacy,can significantly increase serum Clara cell secretory protein levels,reduce CRP, PCT, IL-6 levels,improve clinical symptoms and with high safety.
